Pliaglis Local Anaesthesia

Croma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe

The launch is preceded by an exclusive licensing agreement for Pliaglis® with Canadian dermatology company Crescita Therapeutics Inc. (“Crescita”). The agreement grants Croma the exclusive rights to commercialize Pliaglis in nine countries including Germany, Ireland, Switzerland, Belgium, Luxembourg, the UK and Netherlands and Brazil.

Si eres un profesional de la salud (HCP), por favor inicia sesión para ver información específica sobre nuestros productos.

Inicio de sesión

Registro

* campos obligatorios